Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 16.13% is 23% above its 5-year average of 13.09%, near the high end of its 5-year range (9.16%–16.13%).
As of the fiscal period ended Wednesday, December 31, 2025. 2.19% above its 12-month average of 15.79%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
16.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
15.79%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
14.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
13.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
15.85%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
15.93%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
12.92%
CURRENT VS TTM AVG
+2.19%
CURRENT VS 3Y AVG
+10.74%
CURRENT VS 5Y AVG
+23.19%
CURRENT VS 10Y AVG
+1.77%
CURRENT VS 15Y AVG
+1.27%
CURRENT VS 20Y AVG
+24.86%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+89.10%
vs the sector median at left
United Therapeutics Corporation
Market Cap
$22.23B
Return on Invested Capital (ROIC)
16.13%
TTM Avg
15.79%
3Y Avg
14.56%
5Y Avg
13.09%
Market Cap
$22.14B
Return on Invested Capital (ROIC)
-29.70%
TTM Avg
-31.12%
3Y Avg
-12.69%
5Y Avg
0.19%
Market Cap
$22.45B
Return on Invested Capital (ROIC)
8.47%
TTM Avg
7.82%
3Y Avg
7.13%
5Y Avg
6.49%
Market Cap
$23.38B
Return on Invested Capital (ROIC)
-3.14%
TTM Avg
-4.79%
3Y Avg
9.55%
5Y Avg
20.42%
Market Cap
$20.80B
Return on Invested Capital (ROIC)
-7.95%
TTM Avg
-3.96%
3Y Avg
-1.19%
5Y Avg
-0.87%
Market Cap
$23.72B
Return on Invested Capital (ROIC)
13.62%
TTM Avg
14.65%
3Y Avg
16.90%
5Y Avg
17.70%
Market Cap
$25.02B
Return on Invested Capital (ROIC)
17.57%
TTM Avg
18.00%
3Y Avg
20.73%
5Y Avg
22.79%
Market Cap
$25.77B
Return on Invested Capital (ROIC)
7.39%
TTM Avg
6.30%
3Y Avg
5.64%
5Y Avg
7.56%
Market Cap
$18.52B
Return on Invested Capital (ROIC)
5.48%
TTM Avg
5.58%
3Y Avg
5.01%
5Y Avg
3.94%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| United Therapeutics Corporation (UTHR) | $22.23B | 16.13% | 15.79% | 14.56% | 13.09% |
| Moderna, Inc. (MRNA)vs › | $22.14B | -29.70% | -31.12% | -12.69% | 0.19% |
| STERIS plc (STE)vs › | $22.45B | 8.47% | 7.82% | 7.13% | 6.49% |
| BioNTech SE (BNTX)vs › | $23.38B | -3.14% | -4.79% | 9.55% | 20.42% |
| Viatris Inc. (VTRS)vs › | $20.80B | -7.95% | -3.96% | -1.19% | -0.87% |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.72B | 13.62% | 14.65% | 16.90% | 17.70% |
| Waters Corporation (WAT)vs › | $25.02B | 17.57% | 18.00% | 20.73% | 22.79% |
| Labcorp Holdings Inc. (LH)vs › | $25.77B | 7.39% | 6.30% | 5.64% | 7.56% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.52B | 5.48% | 5.58% | 5.01% | 3.94% |
| Incyte Corporation (INCY)vs › | $25.96B | 20.58% | 10.42% | 9.36% | 7.13% |
ROIC
16.1%
ROE
21.8%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 16.13% |
| 2024-12-31 | 15.44% |
| 2023-12-31 | 13.54% |
| 2022-12-31 | 13.15% |
| 2021-12-31 | 9.16% |
| 2020-12-31 | 11.14% |
| 2019-12-31 | -3.21% |
| 2018-12-31 | 20.01% |
| 2017-12-31 | 18.18% |
| 2016-12-31 | 35.86% |
| 2015-12-31 | 24.94% |
| 2014-12-31 | 23.16% |
| 2013-12-31 | 10.88% |
| 2012-12-31 | 20.09% |
| 2011-12-31 | 17.68% |
| 2010-12-31 | 9.48% |
| 2009-12-31 | 2.76% |
| 2008-12-31 | -5.97% |
| 2007-12-31 | 1.12% |
| 2006-12-31 | 6.31% |
| 2005-12-31 | 15.49% |
| 2004-12-31 | 6.83% |
| 2003-12-31 | -6.79% |
| 2002-12-31 | -10.27% |
| 2001-12-31 | -17.27% |
| 2000-12-31 | -31.74% |
| 1999-12-31 | -60.46% |
| 1998-12-31 | -78.70% |
